Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of toxigenic Clostridium difficile in fecal specimens

Journal of Clinical Microbiology

Volumn 51, Issue 9, 2013, Pages 2908-2912

  Hirvonen, Jari J ^a   Mentula, Silja ^b   Kaukoranta, Suvi Sirkku ^a  

^a VAASA CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION, LABORATORY; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84882773386     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01083-13     Document Type: Article

References (45)

1. Bartlett JG, Gerding DN. 2008. Clinical recognition and diagnosis of Clostridium difficile infection. Clin. Infect. Dis. 46(Suppl 1):S12-S18.
2. Karas JA, Enoch DA, Aliyu SH. 2010. A review of mortality due to Clostridium difficile infection. J. Infect. 61:1-8.
3. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713.
4. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-1179.
5. Elliott B, Squire MM, Thean S, Chang BJ, Brazier JS, Rupnik M, Riley TV. 2011. New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J. Med. Microbiol. 60:1108-1111.
6. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
7. Stewart DB, Berg A, Hegarty J. 2013. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J. Gastrointest. Surg. 17:118-124.
8. Dodek PM, Norena M, Ayas NT, Romney M, Wong H. 21 January 2013. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit. J. Crit. Care [Epub ahead of print.] doi:10.1016 /j.jcrc.2012.11.008.
9. Arroyo LG, Rousseau J, Willey BM, Low DE, Staempfli H, McGeer A, Weese JS. 2005. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J. Clin. Microbiol. 43:5341-5343.
10. Bliss DZ, Johnson S, Clabots CR, Savik K, Gerding DN. 1997. Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients. Diagn. Microbiol. Infect. Dis. 29:1-4.
11. Clabots CR, Gerding SJ, Olson MM, Peterson LR, Gerding DN. 1989. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J. Clin. Microbiol. 27:2386-2387.
12. Marler LM, Siders JA, Wolters LC, Pettigrew Y, Skitt BL, Allen SD. 1992. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 30:514-516.
13. Brazier JS. 1998. The diagnosis of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 41(Suppl 3):29-40.
14. Bruins MJ, Verbeek E, Wallinga JA, Bruijnesteijn van Coppenraet LE, Kuijper EJ, Bloembergen P. 2012. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur. J. Clin. Microbiol. Infect. Dis. 31:3035-3039.
15. Culbreath K, Ager E, Nemeyer RJ, Kerr A, Gilligan PH. 2012. Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J. Clin. Microbiol. 50:3073-3076.
16. Walkty A, Lagacé-Wiens PR, Manickam K, Adam H, Pieroni P, Hoban D, Karlowsky JA, Alfa M. 2013. Evaluation of an algorithmic approach in comparison with the Illumigene assay for laboratory diagnosis of Clostridium difficile infection. J. Clin. Microbiol. 51:1152-1157.
17. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficileinfection (CDI). Clin. Microbiol. Infect. 15:1053-1066.
18. Alonso R, Muñoz C, Peláez T, Cercenado E, Rodríguez-Creixems M, Bouza E. 1997. Rapid detection of toxigenic Clostridium difficile strains by a nested PCR of the toxin B gene. Clin. Microbiol. Infect. 3:145-147.
19. Bélanger SD, Boissinot M, Clairoux N, Picard FJ, Bergeron MG. 2003. Rapid detection of Clostridium difficile in feces by real-time PCR. J. Clin. Microbiol. 41:730-734.
20. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K, Kim SM, Chong Y, Wasito EB. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178-2182.
21. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49:2887-2893.
22. Eastwood K, Else P, Charlett A, Wilcox M. 2009. Comparison of nine commercially available Clostridium difficile toxin detection assays, a realtime PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47:3211-3217.
23. Buchan BW, Mackey TL, Daly JA, Alger G, Denys GA, Peterson LR, Kehl SC, Ledeboer NA. 2012. Multicenter clinical evaluation of the Portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J. Clin. Microbiol. 50:3932-3936.
24. Chapin KC, Dickenson RA, Wu F, Andrea SB. 2011. Comparison of five assays for detection of Clostridium difficile toxin. J. Mol. Diagn. 13:395-400.
25. Le Guern R, Herwegh S, Grandbastien B, Courcol R, Wallet F. 2012. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J. Clin. Microbiol. 50: 3089-3090.
26. Shin BM, Mun SJ, Yoo SJ, Kuak EY. 2012. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens. J. Clin. Microbiol. 50:3765-3767.
27. Terhes G, Urbán E, Sóki J, Nacsa E, Nagy E. 2009. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J. Clin. Microbiol. 47:3478-3481.
28. Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, Shuptar S, Kamboj M, Kiehn TE. 2010. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAPI strain at a cancer hospital. J. Clin. Microbiol. 48:4519-4524.
29. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM. 2010. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48:2082-2086.
30. von Lode P, Rosenberg J, Pettersson K, Takalo H. 2003. A europium chelate for quantitative point-of-care immunoassays using direct surface measurement. Anal. Chem. 75:3193-3201.
31. Hirvonen JJ, Nevalainen M, Tissari P, Salmenlinna S, Rantakokko-Jalava K, Kaukoranta SS. 2012. Rapid confirmation of suspected methicillin-resistant Staphylococcus aureus colonies on chromogenic agars by a new commercial PCR assay, the GenomEra MRSA/SA Diagnose. Eur. J. Clin. Microbiol. Infect. Dis. 31:1961-1968.
32. Hirvonen JJ, von Lode P, Nevalainen M, Rantakokko-Jalava K, Kaukoranta SS. 2012. One-step sample preparation of positive blood cultures for the direct detection of methicillin-sensitive and-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci within one hour using the automated GenomEraCDX™PCR system. Eur. J. Clin. Microbiol. Infect. Dis. 31:2835-2842.
33. Lehmusvuori A, Juntunen E, Tapio AH, Rantakokko-Jalava K, Soukka T, Lövgren T. 2010. Rapid homogeneous PCR assay for the detection of Chlamydia trachomatis in urine samples. J. Microbiol. Methods 83:302-306.
34. Hirvonen JJ, Kaukoranta SS. 2013. Evaluation of a new polymerase chain reaction (PCR) assay, the GenomEra C. difficile, for rapid detection of toxigenic Clostridium difficile in faecal specimens, poster 1858. Program 23rd Eur. Congr. Clin. Microbiol. Infect. Dis. European Society of Clinical Microbiology and Infectious Diseases, Berlin, Germany.
35. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. 1999. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J. Clin. Microbiol. 37:461-463.
36. Ylisiurua P, Koskela M, Vainio O, Tuokko H. 2013. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand. J. Infect. Dis. 45:19-25.
37. Lessa FC, Gould CV, McDonald LC. 2012. Current status of Clostridium difficile infection epidemiology. Clin. Infect. Dis. 55(Suppl 2):S65-S70.
38. Rupnik M, Kato N, Grabnar M, Kato H. 2003. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J. Clin. Microbiol. 41:1118-1125.
39. Humphries RM, Uslan DZ, Rubin Z. 2013. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J. Clin. Microbiol. 51:869-873.
40. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. 2012. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin. Infect. Dis. 55:1209-1215.
41. Matsuki S, Ozaki E, Shozu M, Inoue M, Shimizu S, Yamaguchi N, Karasawa T, Yamagishi T, Nakamura S. 2005. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int. Microbiol. 8:43-48.
42. Kyne L, Warny M, Qamar A, Kelly CP. 2000. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N. Engl. J. Med. 342:390-397.
43. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. 2007. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45:992-998.
44. Wilcox MH. 2012. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin. Microbiol. Infect. 18: 13-20.
45. Pai S, Aliyu SH, Enoch DA, Karas JA. 2012. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 7:e51728. doi:10 .1371/journal.pone.0051728.